Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

Microchip Technology's revenue has been declining for four consecutive quarters. Read more to see why I'm very bearish on ...

Follow all the latest U.S. market action for Tuesday as stocks stage a recovery amid lingering tariff angst; Alphabet ...

The Dow Jones Industrial Average and other major stock indexes held gains in the final hour of trading Tuesday. Palantir Technologies jumped 23% in the stock market today after reporting robust fourth ...

On January 29, Nasdaq reported its fourth quarter and full year 2024 earnings. Nasdaq’s results reflected a year of strong financial and operational performance as well as strategic execution across ...

A warning of a U.S. stock market bubble, advises diversification into value stocks, commodities, and international equities ...

Not every investor picks individual stocks. Some people prefer to buy ETFs that do portfolio diversification for them. While ...

QQQM invests in US large-cap companies, tracking its benchmark, the NASDAQ-100 index. See why I rate the fund a hold.

PepsiCo shares dropped in premarket trading following a weaker-than-expected fourth-quarter revenue report. The company ...

Nasdaq, Inc. (NASDAQ:NDAQ), a global financial services company operating multiple securities exchanges and providing trading, clearing, and technology services, has been navigating a complex market ...